家禽用ワクチン市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

家禽ワクチンの世界市場規模は2029年までに39億米ドルに達する

世界の家禽ワクチン市場は、市場プレーヤーによる技術進歩の高まりと、家禽ワクチンに関連する研究開発活動の活発化によって活況を呈しています。

戦略コンサルティング・市場調査会社大手のBlueWeave Consultingは最近の調査で、2022年の世界の家禽ワクチン市場規模を27億6,300万米ドルと推定しました。2023年から2029年の予測期間中、BlueWeaveは世界の家禽ワクチン市場規模がCAGR 5.7%の大幅な成長を遂げ、2029年には38億5,700万米ドルに達すると予測しています。世界の家禽ワクチン市場の主な成長促進要因には、家禽生産量の増加、家禽製品需要の高まり、疾病予防におけるワクチン接種の重要性に対する意識の高まりなどがあります。家禽人口の拡大と鳥類疾病の流行増加は、家禽ワクチンの需要をさらに押し上げると予想されます。感染肉の消費に伴うリスクや養鶏場が直面する課題を軽減するために、ワクチン接種は疾病予防において重要な役割を果たします。2019年、米国のニワトリの家畜数は1,972万羽、ブラジルの家畜数は1,460万羽であり、適時ワクチン接種の恩恵を受ける可能性のある感受性鳥類が相当数いることが浮き彫りになっています。OIE-WAHISのデータベースによると、特定の期間内に新たに発生した鳥の数は22件に過ぎなかったが、2020年には836件に激増し、推定患者数は279万人に達しました。この鳥類集団における疾病発生の大幅な増加は、家禽ワクチン市場の主要な促進要因となっています。しかし、家禽ワクチンの副作用や高コスト、アクセス制限などが、分析期間中の市場全体の成長を抑制すると予想されます。

本レポートの詳細な分析により、世界の家禽ワクチン市場の成長可能性、今後の動向、統計に関する情報を提供します。また、総市場規模の予測を促進する要因も取り上げています。本レポートは、世界の家禽ワクチン市場の最新技術動向や、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することをお約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の家禽ワクチン市場に関する洞察

• 業界のバリューチェーン分析
• DROC分析
  • 成長促進要因
    • 家禽ワクチンに関連した調査活動の増加
    • 市場関係者による大きな技術進歩
  • 抑制要因
    • 家禽ワクチンの副作用
    • 高コストと制限されたアクセス
  • 機会
    • 鳥インフルエンザの蔓延
    • 不活化ワクチンの使用量の増加
  • 課題
    • 疾患の抗原変異
    • コールドチェーン管理
• 技術の進歩/最近の開発
• 規制の枠組み
• ポーターのファイブフォース分析

第4章 世界の家禽ワクチン市場概要

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
    • 弱毒生ワクチン
    • 不活化ワクチン
    • サブユニットワクチン
    • DNAワクチン
    • 組換えワクチン
  • 剤形別
    • 液体ワクチン
    • フリーズドライワクチン
    • ダクト
  • 病気の種類別
    • 感染性気管支炎
    • 感染性嚢疾患
    • 伝染性喉頭気管炎
    • エッグドロップ症候群
    • アデノウイルス
    • アヒルウイルス性腸炎
    • 封入体肝炎
    • コクシジウム症
    • 鳥インフルエンザ
    • マレック病
    • ニューカッスル病
    • サルモネラ
    • 鳥脳脊髄炎
    • 家禽コレラ
  • 用途別
    • ブロイラー
    • 層
    • ブリーダー
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋（APAC）
    • ラテンアメリカ（LATAM）
    • 中東およびアフリカ（MEA）

第5章 北米の家禽ワクチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • 剤形別
  • 病気の種類別
  • 用途別
  • 国別
    • 米国
    • カナダ

第6章 欧州の家禽ワクチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • 剤形別
  • 病気の種類別
  • 用途別
  • 国別
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • ベルギー
    • ロシア
    • オランダ
    • その他欧州

第7章 アジア太平洋の家禽ワクチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • 剤形別
  • 病気の種類別
  • 用途別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリアとニュージーランド
    • インドネシア
    • マレーシア
    • シンガポール
    • ベトナム
    • APACのその他の地域

第8章 ラテンアメリカの家禽ワクチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • 剤形別
  • 病気の種類別
  • 用途別
  • 国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • ペルー
    • 中南米のその他の地域

第9章 中東およびアフリカの家禽ワクチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • 剤形別
  • 病気の種類別
  • 用途別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • クウェート
    • 南アフリカ
    • ナイジェリア
    • アルジェリア
    • MEAのその他の地域

第10章 競合情勢

• 主要企業とその製品のリスト
• 世界の家禽ワクチン市場シェア分析、2022年
• 動作パラメータによる競合ベンチマーキング
• 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の家禽ワクチン市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

• Boehringer Ingelheim International GmbH
• Ceva
• Zoetis
• Elanco
• Merck & Co., Inc.
• Hester Biosciences Limited
• Vaxxinova International BV
• Venkys India
• Calier
• KM Biologics
• Phibro Animal Health Corporation
• Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

• 定性的調査
  • 一次および2次調査
• 定量的調査
• 市場内訳とデータの三角測量
  • 2次調査
  • 1次調査
• 1次調査回答者の地域別内訳
• 前提と制限

Global Poultry Vaccines Market Size Set to Touch USD 3.9 Billion by 2029.

Global poultry vaccines market is flourishing because of the rising technological advancements by market players and increasing R&D activities associated with poultry vaccines.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global poultry vaccines market size at USD 2.763 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global poultry vaccines market size to grow at a significant CAGR of 5.7% reaching a value of USD 3.857 billion by 2029. Major growth drivers for the global poultry vaccines market include an increasing poultry production, rising demand for poultry products, and growing awareness about the importance of vaccination in disease prevention. The expanding poultry population and the increasing prevalence of avian diseases are expected to further drive the demand for poultry vaccines. To mitigate the risks associated with infected meat consumption and the challenges faced by poultry farms, vaccination plays a crucial role in disease prevention. In 2019, the United States had 19.72 million livestock units of chickens, while Brazil had 14.6 million livestock units, highlighting the considerable number of susceptible birds that could benefit from timely vaccinations. According to the OIE-WAHIS database, there were only 22 new bird outbreaks within a specific period, but this number drastically surged to 836 outbreaks in 2020, with an estimated 2.79 million cases. This significant rise in disease outbreaks among the avian population serves as a key driver for the poultry vaccines market. However, side-effects of poultry vaccines and high costs and limited access are anticipated to restrain the overall market growth during the period in analysis.

Global Poultry Vaccines Market - Overview:

The global poultry vaccines market refers to the worldwide market for vaccines specifically developed for poultry species. Poultry vaccines are used to prevent and control various diseases that affect poultry, including viral, bacterial, and parasitic infections. The market encompasses the research, development, production, and distribution of these vaccines. It plays a crucial role in maintaining the health and productivity of poultry populations, supporting the sustainable growth of the poultry industry. The global poultry vaccines market is driven by increasing poultry production, rising demand for poultry products, and growing awareness of the importance of vaccination in disease prevention.

Impact of COVID-19 on Global Poultry Vaccines Market:

COVID-19 pandemic had a mixed impact on the global poultry vaccines market. On the one hand, there was an increased focus on food safety and biosecurity, which heightened the importance of disease prevention measures, including vaccination, leading to a surge in demand for poultry vaccines. On the other hand, disruptions in the supply chain, restrictions on international trade, and reduced poultry production in some regions posed challenges to the market. Additionally, the diversion of resources toward human health during the pandemic affected R&D activities in the field.

Global Poultry Vaccines Market - By Application:

Based on application, the global poultry vaccines market is divided into Broiler, Layer, and Breeder segments. The breeder segment held the highest market share in 2022 by application due to the increasing number of breeder farms that produce fertile eggs for hatcheries. The enhanced productivity achieved through these breeding farms has greatly contributed to the market's expansion. Government initiatives aimed at vaccinating breeders have played a significant role in driving market growth. Vaccinating breeders not only safeguards the vaccinated birds but also protects the progeny, including broilers. Proactive government policies have resulted in the growth of poultry farmers, breeders, integrators, and feed mills. For example, the Animal Husbandry Department in the state of Andhra Pradesh, India implemented a comprehensive poultry development policy (2016-2020), stimulating production in the poultry sector, promoting egg and chicken processing, and facilitating export activities. Such favorable government initiatives continue to propel the market's growth. Additionally, the market benefits from a favorable regulatory environment and supportive measures that promote sustainable poultry farming practices and ensure food security.

Competitive Landscape:

Major players operating in the global poultry vaccines market include: Boehringer Ingelheim International GmbH, Ceva, Zoetis, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Vaxxinova International BV, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Poultry Vaccines Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Poultry Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Poultry Vaccines Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing Research Activities Associated with Poultry vaccines
    • 3.2.1.2. Huge Technological Advancements by Market Players
  • 3.2.2. Restraints
    • 3.2.2.1. Side-Effects of Poultry Vaccines
    • 3.2.2.2. High Costs and Limited Access
  • 3.2.3. Opportunities
    • 3.2.3.1. Increasing Prevalence of Avian Influenza
    • 3.2.3.2. Increasing Usage of Inactivated Vaccines
  • 3.2.4. Challenges
    • 3.2.4.1. Antigenic Variation of Diseases
    • 3.2.4.2. Cold Chain Management
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Poultry Vaccines Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share and Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Attenuated Live Vaccines
    • 4.2.1.2. Inactivated Vaccines
    • 4.2.1.3. Subunit Vaccines
    • 4.2.1.4. DNA Vaccines
    • 4.2.1.5. Recombinant Vaccines
  • 4.2.2. By Dosage Form
    • 4.2.2.1. Liquid Vaccine
    • 4.2.2.2. Freeze Dried Vaccine
    • 4.2.2.3. Duct
  • 4.2.3. By Disease Type
    • 4.2.3.1. Infectious Bronchitis
    • 4.2.3.2. Infectious Bursal Diseases
    • 4.2.3.3. Infectious Laryngotracheitis
    • 4.2.3.4. Egg Drop Syndrome
    • 4.2.3.5. Adenovirus
    • 4.2.3.6. Duck Viral Enteritis
    • 4.2.3.7. Inclusion Body Hepatitis
    • 4.2.3.8. Coccidiosis
    • 4.2.3.9. Avian Influenza
    • 4.2.3.10. Marek's Disease
    • 4.2.3.11. Newcastle Disease
    • 4.2.3.12. Salmonella
    • 4.2.3.13. Avian Encephalomyelitis
    • 4.2.3.14. Fowl Cholera
  • 4.2.4. By Application
    • 4.2.4.1. Broiler
    • 4.2.4.2. Layer
    • 4.2.4.3. Breeder
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia Pacific (APAC)
    • 4.2.5.4. Latin America (LATAM)
    • 4.2.5.5. Middle East and Africa (MEA)

5. North America Poultry Vaccines Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
  • 5.2.2. By Dosage Form
  • 5.2.3. By Disease Type
  • 5.2.4. By Application
  • 5.2.5. By Country
    • 5.2.5.1. United States
    • 5.2.5.1.1. By Product Type
    • 5.2.5.1.2. By Dosage Form
    • 5.2.5.1.3. By Disease Type
    • 5.2.5.1.4. By Application
    • 5.2.5.2. Canada
    • 5.2.5.2.1. By Product Type
    • 5.2.5.2.2. By Dosage Form
    • 5.2.5.2.3. By Disease Type
    • 5.2.5.2.4. By Application

6. Europe Poultry Vaccines Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Dosage Form
  • 6.2.3. By Disease Type
  • 6.2.4. By Application
  • 6.2.5. By Country
    • 6.2.5.1. Germany
    • 6.2.5.1.1. By Product Type
    • 6.2.5.1.2. By Dosage Form
    • 6.2.5.1.3. By Disease Type
    • 6.2.5.1.4. By Application
    • 6.2.5.2. United Kingdom
    • 6.2.5.2.1. By Product Type
    • 6.2.5.2.2. By Dosage Form
    • 6.2.5.2.3. By Disease Type
    • 6.2.5.2.4. By Application
    • 6.2.5.3. Italy
    • 6.2.5.3.1. By Product Type
    • 6.2.5.3.2. By Dosage Form
    • 6.2.5.3.3. By Disease Type
    • 6.2.5.3.4. By Application
    • 6.2.5.4. France
    • 6.2.5.4.1. By Product Type
    • 6.2.5.4.2. By Dosage Form
    • 6.2.5.4.3. By Disease Type
    • 6.2.5.4.4. By Application
    • 6.2.5.5. Spain
    • 6.2.5.5.1. By Product Type
    • 6.2.5.5.2. By Dosage Form
    • 6.2.5.5.3. By Disease Type
    • 6.2.5.5.4. By Application
    • 6.2.5.6. Belgium
    • 6.2.5.6.1. By Product Type
    • 6.2.5.6.2. By Dosage Form
    • 6.2.5.6.3. By Disease Type
    • 6.2.5.6.4. By Application
    • 6.2.5.7. Russia
    • 6.2.5.7.1. By Product Type
    • 6.2.5.7.2. By Dosage Form
    • 6.2.5.7.3. By Disease Type
    • 6.2.5.7.4. By Application
    • 6.2.5.8. The Netherlands
    • 6.2.5.8.1. By Product Type
    • 6.2.5.8.2. By Dosage Form
    • 6.2.5.8.3. By Disease Type
    • 6.2.5.8.4. By Application
    • 6.2.5.9. Rest of Europe
    • 6.2.5.9.1. By Product Type
    • 6.2.5.9.2. By Dosage Form
    • 6.2.5.9.3. By Disease Type
    • 6.2.5.9.4. By Application

7. Asia-Pacific Poultry Vaccines Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Dosage Form
  • 7.2.3. By Disease Type
  • 7.2.4. By Application
  • 7.2.5. By Country
    • 7.2.5.1. China
    • 7.2.5.1.1. By Product Type
    • 7.2.5.1.2. By Dosage Form
    • 7.2.5.1.3. By Disease Type
    • 7.2.5.1.4. By Application
    • 7.2.5.2. India
    • 7.2.5.2.1. By Product Type
    • 7.2.5.2.2. By Dosage Form
    • 7.2.5.2.3. By Disease Type
    • 7.2.5.2.4. By Application
    • 7.2.5.3. Japan
    • 7.2.5.3.1. By Product Type
    • 7.2.5.3.2. By Dosage Form
    • 7.2.5.3.3. By Disease Type
    • 7.2.5.3.4. By Application
    • 7.2.5.4. South Korea
    • 7.2.5.4.1. By Product Type
    • 7.2.5.4.2. By Dosage Form
    • 7.2.5.4.3. By Disease Type
    • 7.2.5.4.4. By Application
    • 7.2.5.5. Australia & New Zealand
    • 7.2.5.5.1. By Product Type
    • 7.2.5.5.2. By Dosage Form
    • 7.2.5.5.3. By Disease Type
    • 7.2.5.5.4. By Application
    • 7.2.5.6. Indonesia
    • 7.2.5.6.1. By Product Type
    • 7.2.5.6.2. By Dosage Form
    • 7.2.5.6.3. By Disease Type
    • 7.2.5.6.4. By Application
    • 7.2.5.7. Malaysia
    • 7.2.5.7.1. By Product Type
    • 7.2.5.7.2. By Dosage Form
    • 7.2.5.7.3. By Disease Type
    • 7.2.5.7.4. By Application
    • 7.2.5.8. Singapore
    • 7.2.5.8.1. By Product Type
    • 7.2.5.8.2. By Dosage Form
    • 7.2.5.8.3. By Disease Type
    • 7.2.5.8.4. By Application
    • 7.2.5.9. Vietnam
    • 7.2.5.9.1. By Product Type
    • 7.2.5.9.2. By Dosage Form
    • 7.2.5.9.3. By Disease Type
    • 7.2.5.9.4. By Application
    • 7.2.5.10. Rest of APAC
    • 7.2.5.10.1. By Product Type
    • 7.2.5.10.2. By Dosage Form
    • 7.2.5.10.3. By Disease Type
    • 7.2.5.10.4. By Application

8. Latin America Poultry Vaccines Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Dosage Form
  • 8.2.3. By Disease Type
  • 8.2.4. By Application
  • 8.2.5. By Country
    • 8.2.5.1. Brazil
    • 8.2.5.1.1. By Product Type
    • 8.2.5.1.2. By Dosage Form
    • 8.2.5.1.3. By Disease Type
    • 8.2.5.1.4. By Application
    • 8.2.5.2. Mexico
    • 8.2.5.2.1. By Product Type
    • 8.2.5.2.2. By Dosage Form
    • 8.2.5.2.3. By Disease Type
    • 8.2.5.2.4. By Application
    • 8.2.5.3. Argentina
    • 8.2.5.3.1. By Product Type
    • 8.2.5.3.2. By Dosage Form
    • 8.2.5.3.3. By Disease Type
    • 8.2.5.3.4. By Application
    • 8.2.5.4. Peru
    • 8.2.5.4.1. By Product Type
    • 8.2.5.4.2. By Dosage Form
    • 8.2.5.4.3. By Disease Type
    • 8.2.5.4.4. By Application
    • 8.2.5.5. Rest of LATAM
    • 8.2.5.5.1. By Product Type
    • 8.2.5.5.2. By Dosage Form
    • 8.2.5.5.3. By Disease Type
    • 8.2.5.5.4. By Application

9. Middle East & Africa Poultry Vaccines Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Dosage Form
  • 9.2.3. By Disease Type
  • 9.2.4. By Application
  • 9.2.5. By Country
    • 9.2.5.1. Saudi Arabia
    • 9.2.5.1.1. By Product Type
    • 9.2.5.1.2. By Dosage Form
    • 9.2.5.1.3. By Disease Type
    • 9.2.5.1.4. By Application
    • 9.2.5.2. UAE
    • 9.2.5.2.1. By Product Type
    • 9.2.5.2.2. By Dosage Form
    • 9.2.5.2.3. By Disease Type
    • 9.2.5.2.4. By Application
    • 9.2.5.3. Qatar
    • 9.2.5.3.1. By Product Type
    • 9.2.5.3.2. By Dosage Form
    • 9.2.5.3.3. By Disease Type
    • 9.2.5.3.4. By Application
    • 9.2.5.4. Kuwait
    • 9.2.5.4.1. By Product Type
    • 9.2.5.4.2. By Dosage Form
    • 9.2.5.4.3. By Disease Type
    • 9.2.5.4.4. By Application
    • 9.2.5.5. South Africa
    • 9.2.5.5.1. By Product Type
    • 9.2.5.5.2. By Dosage Form
    • 9.2.5.5.3. By Disease Type
    • 9.2.5.5.4. By Application
    • 9.2.5.6. Nigeria
    • 9.2.5.6.1. By Product Type
    • 9.2.5.6.2. By Dosage Form
    • 9.2.5.6.3. By Disease Type
    • 9.2.5.6.4. By Application
    • 9.2.5.7. Algeria
    • 9.2.5.7.1. By Product Type
    • 9.2.5.7.2. By Dosage Form
    • 9.2.5.7.3. By Disease Type
    • 9.2.5.7.4. By Application
    • 9.2.5.8. Rest of MEA
    • 9.2.5.8.1. By Product Type
    • 9.2.5.8.2. By Dosage Form
    • 9.2.5.8.3. By Disease Type
    • 9.2.5.8.4. By Application

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Poultry Vaccines Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Poultry Vaccines Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Boehringer Ingelheim International GmbH
• 12.2. Ceva
• 12.3. Zoetis
• 12.4. Elanco
• 12.5. Merck & Co., Inc.
• 12.6. Hester Biosciences Limited
• 12.7. Vaxxinova International BV
• 12.8. Venkys India
• 12.9. Calier
• 12.10. KM Biologics
• 12.11. Phibro Animal Health Corporation
• 12.12. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations